- Active not recruitingPHASE3
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
This study is testing a new medicine, ARV-471, against an existing treatment, fulvestrant, for advanced breast cancer that has spread. It's for people who have already had certain hormone therapies. The aim is to see if ARV-471 is safe and effective.
For: Advanced Breast CancerUnited States · Argentina · Australia - Ongoing, recruitingHuman Pharmacology (Phase I)- Other
A Phase 1b Trial of ARV-471 in Combination with Everolimus in Patients with ER+, HER2– Advanced or Metastatic Breast Cancer
This study is testing a new combination of two drugs, ARV-471 and Everolimus, for advanced breast cancer that has specific characteristics (ER+, HER2-). Doctors want to find the safest dose and see how well patients tolerate this new treatment. It's an early-stage study.
For: HER2– Advanced or Metastatic Breast CancerSpain